PMC9975149_01
Longitudinal changes of HBV DNA, HCV RNA, and ALT levels of the HBV and HCV-coinfected patient. PegINT, pegylated interferon.
fmed-10-1136111-g001.jpg
PMC9975149_01_fmed-10-1136111-g001.jpg
F1
The clinical course is shown in Figure 1, ALT and bilirubin levels progressively declined after entecavir therapy.